肿瘤规范化、标准化诊治第16讲可切除胃癌的新辅助化疗

暂未订购

导出

作者马艳玲王华庆

机构地区天津医科大学肿瘤医院内科

出处《中国医刊》 CAS 2008年第11期24-26,共3页 Chinese Journal of Medicine

关键词恶性肿瘤新辅助化疗胃癌标准化诊治世界范围地域差异西方国家

参考文献5

1Cunningham, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for respectable gastroesophageal cancer [ J ]. N Engl J Med, 2006, 355 ( 1 ) : 11 - 20.
2Rose P, Nicolson M, Cunningham D, et al. Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous - infusion fluorouracil ( PVI 5 - Fu) with epirubicin, cisplatin, and PVI 5 -Fu in advanced esophagogastric cancer [ J ]. J Clin Oncol, 2002, 20(8): 1996 -2004.
3Webb A, Cunningham d, Scarffe JH, et al. Randomized trial compa- ring epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin,and methotrexate in advanced sophagogastric cancer[ J]. J Clin Oncol, 1997, 15(1):261-267.
4Hartgrink HH, van de Vetde C J, Putter H, et al. Neo - adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomized FAMTX triM[J]. Eur J Surg Oncol, 2004, 30 (6) :643 -649.
5Ychou M, Pignon JP, Lasser P, et al. Pase Ⅲ preliminary results of preoperative fluorouracil(F) and cisplatin(P) versus surgery alone in adenocarcinoma of stomach and lower esophagus(ASLE) :FNLCC 94012- FFCD 9703 trial[ J ]. J Clin Oncol, 2006, 24: 4026.

中国医刊

2008年第11期

内容加载中请稍等...